Core Scientific’s (CORZ) Buy Rating Reiterated at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH reaffirmed their buy rating on shares of Core Scientific (NASDAQ:CORZFree Report) in a research report report published on Tuesday morning, MarketBeat.com reports. They currently have a $14.50 target price on the stock.

CORZ has been the subject of a number of other reports. BTIG Research upped their price target on Core Scientific from $10.00 to $15.00 and gave the stock a buy rating in a report on Wednesday, June 26th. HC Wainwright upped their target price on Core Scientific from $5.00 to $11.00 and gave the company a buy rating in a research note on Tuesday, June 25th.

Get Our Latest Analysis on CORZ

Core Scientific Stock Performance

CORZ opened at $10.12 on Tuesday. The business has a 50 day moving average price of $6.30 and a 200 day moving average price of $4.03. Core Scientific has a twelve month low of $2.61 and a twelve month high of $10.70.

Core Scientific (NASDAQ:CORZGet Free Report) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.14. The business had revenue of $179.29 million for the quarter, compared to analyst estimates of $139.60 million. On average, research analysts expect that Core Scientific will post -0.8 earnings per share for the current fiscal year.

Insider Activity at Core Scientific

In related news, insider Todd M. Duchene sold 7,321 shares of the company’s stock in a transaction on Tuesday, June 25th. The stock was sold at an average price of $9.39, for a total value of $68,744.19. Following the completion of the transaction, the insider now directly owns 359,877 shares in the company, valued at $3,379,245.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Core Scientific news, insider Todd M. Duchene sold 7,321 shares of the company’s stock in a transaction on Tuesday, June 25th. The stock was sold at an average price of $9.39, for a total value of $68,744.19. Following the sale, the insider now directly owns 359,877 shares in the company, valued at $3,379,245.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Todd M. Duchene sold 3,770 shares of the company’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $9.99, for a total value of $37,662.30. Following the completion of the sale, the insider now owns 393,428 shares in the company, valued at $3,930,345.72. The disclosure for this sale can be found here.

Institutional Trading of Core Scientific

A number of large investors have recently bought and sold shares of the stock. Aspect Partners LLC bought a new stake in Core Scientific in the first quarter valued at $29,000. Hexagon Capital Partners LLC bought a new stake in shares of Core Scientific during the first quarter worth $34,000. Lindbrook Capital LLC bought a new stake in shares of Core Scientific during the first quarter worth $65,000. Fiduciary Alliance LLC bought a new stake in shares of Core Scientific during the first quarter worth $84,000. Finally, Dorsey & Whitney Trust CO LLC bought a new stake in shares of Core Scientific during the first quarter worth $122,000.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Read More

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.